Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Samadhiya, Swapnil
- Rare Case of Upper Extremity Deep Vein Thrombosis After A Wasp Bite
Abstract Views :200 |
PDF Views:0
Authors
Affiliations
1 PIMS, Udaipur, IN
1 PIMS, Udaipur, IN
Source
The Indian Practitioner, Vol 71, No 3 (2018), Pagination: 36-38Abstract
Upper extremity deep venous thrombosis (UEDVT) usually refers to thrombosis of the axillary or subclavian veins. UEDVT is much less common than its lower extremity counterpart, constituting only about 5% of all documented DVTs. UEDVT due to wasp bite is not reported yet. We, therefore, hereby present a rare case of UEDVT in a 44 year old male who had history of wasp bite leading to development of right subclavian vein thrombosis which shows that wasp bite is also among the rarest causes of UEDVT.
References
- a) Sabiston textbook of surgery 18th edition,ebook, chapter 68 – venous disease, Deep Venous Thrombosis of the Upper Extremity
- b) Prandoni P, Polistena P, Bernardi E, et al. Upperextremity deep vein thrombosis: risk factors, diagnosis and complications. Arch Intern Med. 1997;157: 57–62.
- c) Horattas MC, Wright DJ, Fenton AH, et al. Changing concepts of deep venous thrombosis of the upper extremity: report of a series and review of the literature. Surgery. 1988; 104: 561–567
- d) Becker DM, Philbrick JT, Walker FB. Axillary and subclavian venous thrombosis: prognosis and treatment. Arch Intern Med. 1991; 151: 1934–1943.
- e) Fraschini G, Jadeja J, Lawson M, et al. Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. J Clin Oncol. 1987; 5: 672–678.
- f) Lindblad B, Tengborn L, Bergqvist D. Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae. Eur J Vasc Surg. 1988; 2: 161–165
- g) Zell L, Kindermann W, Marschall F, et al. PagetSchroetter syndrome in sports activities: case study and literature review. Angiology. 2001; 52: 337–342
- h) Martinelli I, Cattaneo M, Panzeri D, et al. Risk factors for deep venous thrombosis of the upper extremities. Ann Intern Med. 1997; 126: 707–711
- i) Hicken GJ, Ameli M. Management of subclavianaxillary vein thrombosis: a review. Can J Surg. 1998; 41: 13–25.
- j) E. Habermann, “Bee and wasp venoms,”Science, vol. 177, no.4046, pp. 314–322, 1972.
- k) Y. Li, L. Chi, D. J. Stechschulte, and K. N. Dileepan, “Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-α,” Microvascular Research, vol. 61, no. 3, pp. 253–262, 2001.
- l) R. McMillan, M. J. Bakich, and R. J. Yelenosky, “The adrenalin binding site on human platelets,”British Journal of Haematology, vol. 41, no. 4, pp. 597– 604, 1979.
- m) E.P.McFadden,J.G.Clarke,G.J.Davies,J.C.Kaski,A .W. Haider, and A. Maseri, “Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina,”New England Journal of Medicine, vol.324, no. 10, pp. 648–654, 1991.
- n) H. Yang, X. Xu, D. Ma, K. Zhang, and R. Lai, “A phospholipase A1 platelet activator from the wasp venom of Vespa magnifica (Smith),”Toxic on, vol. 51, no. 2, pp. 289–296, 2008.
- A Rare Case of Chronic Myeloid Leukaemia in a Young Male Masquerading as Essential Thrombocytosis
Abstract Views :195 |
PDF Views:0
Authors
Affiliations
1 Deptt of Medicine, JLN MC Ajmer, Rajasthan, IN
1 Deptt of Medicine, JLN MC Ajmer, Rajasthan, IN
Source
The Indian Practitioner, Vol 71, No 11 (2018), Pagination: 38-39Abstract
The children and young adults constitute only a small percentage of chronic myeloid leukaemia (CML) patients. We are presenting here a unique case of CML in a young male masquerading as essential thrombocytosis (ET) with non-specific signs & symptoms. The patient was later managed with newer tyrosine kinase inhibitor because of an inadequate response from imatinib. The patient is now doing well and is in regular follow up.References
- Pemmaraju N, Kantarjian H, Shan J, JabbourE,QuintasCardama A, Verstovsek S, et al. Analysisofoutcomes in adolescents and young adults with chronic myelogenous leukemia treated withupfront tyrosine kinase inhibitor therapy. Haematologica. 2012 Jul;97(7):1029–35.
- Baccarani M, Dreyling M. Chronic myeloidleukaemia: ESMO Clinical Practice Guidelinesfordiagnosis, treatment and follow-up. Ann Oncol.2010 May 1;21(suppl_5):v1657.
- Raut L, Bohara VV, Ray SS, ChakrabartiP,Chaudhuri U. Chronic myeloid leukemiainchildren and adolescents: A single centerexperience from Eastern India. South Asian JCancer. 2013;2(4):260–4.
- Cortes J, De Souza C, Ayala-Sanchez M, BenditI,BestAguilera C, Enrico A, et al. Current patientmanagement of chronic myeloid leukemia in LatinAmerica: a study by the Latin American Leukemia Net (LALNET). Cancer. 2010 Nov 1;116(21):4991–5000.
- Peeters M, Koren G, Jakubovicz D, ZipurskyA.Physician compliance and relapse rates of acutelymphoblasticleukemia in children. ClinPharmacolTher. 1988 Mar;43(3):228–32.